Synovus Financial Corp boosted its position in Cerner Co. (NASDAQ:CERN) by 6.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,065 shares of the company’s stock after purchasing an additional 2,629 shares during the period. Synovus Financial Corp’s holdings in Cerner were worth $3,204,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Advisory Services Network LLC increased its stake in Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after purchasing an additional 70 shares in the last quarter. Acrospire Investment Management LLC grew its holdings in Cerner by 100.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,800 shares of the company’s stock valued at $120,000 after buying an additional 900 shares during the last quarter. Fuller & Thaler Asset Management Inc. acquired a new stake in Cerner during the 3rd quarter valued at $121,000. Pacad Investment Ltd. acquired a new stake in Cerner during the 2nd quarter valued at $130,000. Finally, Sun Life Financial INC grew its holdings in Cerner by 23,700.0% during the 2nd quarter. Sun Life Financial INC now owns 2,142 shares of the company’s stock valued at $142,000 after buying an additional 2,133 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.
In other news, Chairman Clifford W. Illig sold 530,000 shares of the firm’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $65.54, for a total transaction of $34,736,200.00. Following the sale, the chairman now owns 1,229,719 shares in the company, valued at $80,595,783.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Clifford W. Illig sold 4,000 shares of the firm’s stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $65.96, for a total value of $263,840.00. Following the sale, the chairman now owns 1,229,719 shares in the company, valued at approximately $81,112,265.24. The disclosure for this sale can be found here. Insiders have sold 833,470 shares of company stock worth $55,418,902 in the last 90 days. Insiders own 13.11% of the company’s stock.
Shares of Cerner Co. (NASDAQ CERN) opened at $70.09 on Wednesday. Cerner Co. has a fifty-two week low of $47.01 and a fifty-two week high of $73.86. The company has a current ratio of 2.77, a quick ratio of 2.75 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $23,199.24, a price-to-earnings ratio of 30.88, a PEG ratio of 2.25 and a beta of 0.94.
Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.62 by ($0.01). Cerner had a return on equity of 18.03% and a net margin of 13.37%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the business earned $0.59 EPS. Cerner’s revenue for the quarter was up 7.7% compared to the same quarter last year. research analysts expect that Cerner Co. will post 2.25 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/12/06/cerner-co-cern-shares-bought-by-synovus-financial-corp.html.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.